Provided by Tiger Fintech (Singapore) Pte. Ltd.

Catalyst Pharmaceuticals

21.24
+0.06000.28%
Volume:461.93K
Turnover:9.86M
Market Cap:2.59B
PE:13.54
High:21.50
Open:21.18
Low:21.05
Close:21.18
Loading ...

We Think Catalyst Pharmaceuticals' (NASDAQ:CPRX) Robust Earnings Are Conservative

Simply Wall St.
·
05 Mar

Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference

GlobeNewswire
·
04 Mar

Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
04 Mar

Catalyst Pharmaceuticals Is Maintained at Outperform by Baird

Dow Jones
·
03 Mar

Catalyst Pharmaceuticals Inc. Stock Rallies 5.7%, Outperforms Competitors

Dow Jones
·
01 Mar

Stock Track | Catalyst Pharmaceuticals Stock Soars 5.03% on Strong Full-Year 2024 Earnings

Stock Track
·
01 Mar

Oppenheimer Adjusts Price Target on Catalyst Pharmaceuticals to $32 From $31, Maintains Outperform Rating

MT Newswires Live
·
28 Feb

Bank of America Securities Sticks to Its Buy Rating for Catalyst Pharma (CPRX)

TIPRANKS
·
28 Feb

Catalyst Pharmaceuticals Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
28 Feb

Catalyst Pharmaceuticals Inc (CPRX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...

GuruFocus.com
·
28 Feb

Catalyst Pharmaceuticals Reports Strong Growth Amid Challenges

TIPRANKS
·
28 Feb

BUZZ-Catalyst rises on upbeat 2025 revenue forecast, quarterly results beat

Reuters
·
28 Feb

Here's What's Driving Catalyst Pharmaceuticals Stock 8% Higher Today

Motley Fool
·
28 Feb

Catalyst Pharmaceuticals Price Target Maintained With a $33.00/Share by Stephens & Co.

Dow Jones
·
27 Feb

Stock Track | Catalyst Pharmaceuticals Soars 10.84% on Robust Q4 Results and Strong Product Growth

Stock Track
·
27 Feb

Stock Track | Catalyst Pharmaceuticals Soars 8.6% in Pre-Market on Strong Q4 Results and Robust Product Growth

Stock Track
·
27 Feb

Is Janus Henderson Small Cap Growth Alpha ETF (JSML) a Strong ETF Right Now?

Zacks
·
27 Feb

Catalyst (CPRX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks
·
27 Feb

Stock Track | Catalyst Pharmaceuticals Soars 8.36% as Q4 Results Beat Estimates, Fueled by FIRDAPSE and AGAMREE Growth

Stock Track
·
27 Feb

Catalyst Pharmaceutical (CPRX) Tops Q4 Earnings and Revenue Estimates

Zacks
·
27 Feb